Patient Financial News

Sun Pharma, India's largest drugmaker, is betting on innovative therapies to fuel growth in an increasingly competitive Indian pharma market. The company launched novel therapy sovateltide under brand name Tyvalzi in September last year in India for treating ischemic stroke, under an exclusive licensing agreement from US-based Pharmazz. Sovateltide is generating good clinical outcomes on Indian patients, a senior executive said.

By Dietrich Knauth

Arcatron Mobility, a fast-growing consumer medical company, said it has raised growth capital from OrbiMed, a global healthcare-focused investment firm. Existing investors BL Taparia Family Office, Chona Family Office, MGA Ventures and founders of Arcatron also participated in the round. The funds will be utilized to ramp up R&D efforts, develop new products and enhance branding and marketing. Most of Orbimed’s deals are in the range of $15 million to $35 million «This investment is a catalyst for expanding product development and reaching more customers. We are excited about the opportunities that this partnership with OrbiMed opens up,» said Arcatron's co-founder Ganesh Sonawane.

Researchers in Canada have developed a novel approach to treat liver cancers using magnet-guided microrobots in an MRI device. Guided by an external magnetic field, miniature biocompatible robots, made of iron oxide nanoparticles, can theoretically provide medical treatment in a very targeted manner, the researchers said. However, there has been a technical obstacle: the force of gravity of these microrobots exceeds that of the magnetic force, which limits their guidance when the tumour is located higher than the injection site, they said. «To solve this problem, we developed an algorithm that determines the position that the patient's body should be in for a clinical MRI to take advantage of gravity and combine it with the magnetic navigation force,» said Gilles Soulez, a researcher at the University of Montreal.

Cybersecurity experts are warning that hospitals around the United States are at risk for attacks such as the one that's crippling operations at a premier Midwestern children’s hospital

Jardiance (empagliflozin) 10mg dosage form has now been approved by the Central Drugs Standard Control Organisation of India for the treatment of chronic kidney disease (CKD), as an additional indication. This indication approval allows the nephrologists and cardiologists to use Jardiance 10mg tablets for the treatment of CKD in eligible patients. Jardiance in clinical trials has found to reduce the risk of sustained decline in estimated glomerular filtration rate (eGFR) (for patients with eGFR 30-90), end-stage kidney disease, cardiovascular death, and hospitalization in adults with chronic kidney disease (CKD) at risk of progression.

India, Mumbai, 14th February 2024: Metropolis Healthcare Limited, India’s leading diagnostic service provider, today announces its collaboration with QritiveTM, a leading provider of AI solutions for pathology labs globally. This partnership is set to augment Metropolis' cancer diagnosis capabilities through the integration of state-of-the-art AI technology.

tuberculosis (TB) patients, an advance that may lead to personalised treatments for the bacterial disease. The study, published in the journal iScience, analysed multimodal data including diverse biomedical data from clinical tests, genomics, medical imaging and drug prescriptions from TB patients. By analysing data from patients with varying levels of drug resistance, the researchers discovered biomedical features predictive of treatment failure. They also uncovered drug regimens effective against specific sets of drug-resistant TB patients.

health insurance scheme at the AIIMS here since September 2018, with a majority of the patients seeking treatment in the departments of medical oncology followed by ophthalmology, general medicine, orthopaedics and neurosurgery. As far as complex surgeries are concerned, 730 procedures for congenital heart diseases have been performed followed by 557 total hip replacements and 148 total knee replacements under the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). According to data provided by the AIIMS, 5,179 beneficiaries availed benefits of the scheme under medical oncology followed by 4,275 under the department of ophthalmology, 3,169 under general medicine, 2,260 under orthopaedics and 2,223 under neurosurgery till January 24. «The AIIMS, Delhi proudly announces the successful and effective implementation of the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (ABPMJAY) scheme. AIIMS has a centralised Ayushman Bharat Kendra located near gate no 1 which runs 24x7 for the smooth implementation of the scheme,» the hospital said in a statement.

Two years after Thailand made pot legal, the country appears set to crack down on its freewheeling drug market with a ban on “recreational” use

Alaskapox, a virus first identified in 2015, has recently claimed the life of an elderly Alaskan man, marking the first known human fatality linked with this pathogen, according to officials.The man, from the Kenai Peninsula (just south of Anchorage), was hospitalized in November due to a worsening infection that impacted the range of motion in his arm, Alaskan public health officials stated on Feb. 9.

(Reuters) — Incyte (NASDAQ:INCY) Corp on Tuesday reported fourth-quarter profit below Wall Street estimates, hit by higher costs related to its products such as skin disorder drug Opzelura and forecast weak sales for its lead product Jakafi this year.

West Virginia lawmakers are pushing to make the state the 12th in the nation to ban smoking in cars with children

health and fitness space are increasingly leveraging artificial intelligence to enhance their offerings. While these startups embrace the technology, they also stress that it cannot do certain things as good as humans do – like in motivating a user. According to consulting platform GlobalData, spending on AI platforms in the healthcare sector globally is projected to grow $18.8 billion by 2027 from $4.8 billion in 2022.

Good morning,

TruDoc Healthcare, the GCC's telehealth and virtual care provider, has acquired Mumbai-based chronic disease management platform Wellthy Therapeutics, according to a company statement. Wellthy Therapeutics, a digital therapeutics (DTx) company, develops and deploys digital therapeutic candidates for commercialisation in indications across cardiology, nephrology and diabetes. It helps medication and health brands achieve their commercial goals by building and launching customised digital health solutions, powered by its disease-agnostic, modular, software-as-a-medical-device (SaMD) platform, according to the company website.

investment decisions, carefully considering our risk profiles. The concept of patient, long-term investing unconsciously mirrors Darwin’s principles in evolutionary biology. Charles Darwin’s theory of evolution revolves around allowing time to shape future generations.

Investing.com-- Shares of Australian pharmaceutical giant CSL Ltd (ASX:CSL) tumbled on Monday after it said that a phase 3 trial for a drug to treat second heart attacks had failed to meet its primary endpoint in efficacy.

₹20,000 a month, more than half of which goes into repaying the loan she took to study nursing in a private college. Jose’s day starts with checking the inventory and the handover of patient data from nurses in the previous shift. Then she proceeds to accompany the doctors on their rounds.

King Charles said, “I would like to express my most heartfelt thanks for the many messages of support and good wishes I have received in recent days". On Monday, Buckingham Palace announced that King Charles, 75, had been diagnosed with a form of cancer, less than 18 months into his reign, adding that he would postpone some engagements to undergo treatment.

ALSO READ: PM Modi banters with MPs during surprise lunch, reveals he sleeps for 3.5 hours, doesn't eat after 6 pm Speaking in the Lok Sabha on Saturday, PM Modi said, "All the honorable members of the House have played an important role in the entire process. It is time that I congratulate all the honorable MPs, both as the leader of this House and as your friend." He said the 17th Lok Sabha set many benchmarks. "These five years were about reform, perform, transform in the country.